UTERINE LEIOMYOSARCOMA

UTERINE LEIOMYOSARCOMA was reported 80 times

These drug classes are most commonly taken by patients reporting UTERINE LEIOMYOSARCOMA:

# Drug Count
0 Microtubule Inhibitor [EPC] 10
1 Alkylating Drug [EPC] 6
2 Kinase Inhibitor [EPC] 4
3 Calcium Channel Blocker [EPC] 3
4 Dihydropyridine Calcium Channel Blocker [EPC] 3
5 Interferon beta [EPC] 3
6 Nonsteroidal Anti-inflammatory Drug [EPC] 3
7 Progestin [EPC] 3
8 Progestin-containing Intrauterine System [EPC] 3
9 Complement Inhibitor [EPC] 2
10 Corticosteroid [EPC] 2
11 Vitamin C [EPC] 2
12 Aminosalicylate [EPC] 1
13 Angiotensin 2 Receptor Blocker [EPC] 1
14 Antirheumatic Agent [EPC] 1
15 Aromatase Inhibitor [EPC] 1
16 Atypical Antipsychotic [EPC] 1
17 Azole Antifungal [EPC] 1
18 CD20-directed Cytolytic Antibody [EPC] 1
19 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
21 Factor Xa Inhibitor [EPC] 1
22 Folate Analog Metabolic Inhibitor [EPC] 1
23 HER2/neu Receptor Antagonist [EPC] 1
24 Integrin Receptor Antagonist [EPC] 1
25 Interleukin-12 Antagonist [EPC] 1
26 Interleukin-23 Antagonist [EPC] 1
27 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1
28 Opioid Agonist [EPC] 1
29 Orexin Receptor Antagonist [EPC] 1
30 Platelet Aggregation Inhibitor [EPC] 1
31 Platinum-based Drug [EPC] 1
32 Proton Pump Inhibitor [EPC] 1
33 RANK Ligand Inhibitor [EPC] 1
34 Serotonin-3 Receptor Antagonist [EPC] 1
35 Sulfonamide Antimicrobial [EPC] 1
36 Thalidomide Analog [EPC] 1
37 Tumor Necrosis Factor Blocker [EPC] 1
38 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
39 Vitamin B12 [EPC] 1
40 Vitamin D [EPC] 1
41 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1
42 mTOR Inhibitor Immunosuppressant [EPC] 1